NASDAQ: PSTV - Plus Therapeutics, Inc.

Lønnsomhet i seks måneder: -51.99%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Plus Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Plus Therapeutics, Inc.

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186Re obisbemeda, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers.

flere detaljer
The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2000-11-16
ISIN US72941H4002
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://plustherapeutics.com
Цена ао 0.76
Prisendring per dag: +6.62% (0.68)
Prisendring per uke: -39.58% (1.2)
Prisendring per måned: -39.58% (1.2)
Prisendring over 3 måneder: -43.36% (1.28)
Prisendring over seks måneder: -51.99% (1.51)
Prisendring per år: -63.57% (1.99)
Prisendring over 3 år: -28.22% (1.01)
Prisendring over 5 år: -67.19% (2.21)
Prisendring over 10 år: 0% (0.725)
Prisendring siden begynnelsen av året: -32.87% (1.08)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 1.22 9
P/BV -4.45 0
P/E 0 0
EV/EBITDA -0.1293 0
Total: 4.88

Effektivitet

Navn Betydning Karakter
ROA, % -116.93 0
ROE, % 987.83 10
Total: 3.33

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.3325 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 63.77 8
Lønnsomhet Ebitda, % 370.11 10
Lønnsomhet EPS, % -96.93 0
Total: 5.8
Flere detaljer

Institusjoner Volum Dele, %
Renaissance Technologies, LLC 33000 0.77
Vanguard Group Inc 32541 0.76
Geode Capital Management, LLC 26543 0.62
Citadel Advisors Llc 16839 0.39
Ground Swell Capital, LLC 14303 0.33
UBS Group AG 8899 0.21
Blackrock Inc. 6960 0.16
Tower Research Capital LLC (TRC) 572 0.01
Osaic Holdings Inc 133 0
JP Morgan Chase & Company 99 0



Veileder Stillingstittel Betaling Fødselsår
Dr. Marc H. Hedrick M.B.A., M.D. President, CEO & Director 945.34k 1963 (62 år)
Mr. Andrew J. Sims CPA VP of Finance & CFO 498.51k 1973 (52 år)
Ms. Desiree Smith Corporate Controller, Principal Financial & Accounting Officer N/A 1964 (61 år)
Dr. John K. Fraser Chief Scientist N/A 1961 (64 år)

Adresse: United States, Austin. TX, 4200 Marathon Boulevard - åpne i Google maps, åpne Yandex-kart
Nettsted: https://plustherapeutics.com